Bio-Techne
TECH
#1203
Rank
$12.77 B
Marketcap
$325.51
Share price
-1.48%
Change (1 day)
-31.25%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Earnings for Bio-Techne (TECH)

Earnings in 2022 (TTM): $0.34 B

According to Bio-Techne's latest financial reports the company's current earnings (TTM) are $0.34 B. In 2021 the company made an earning of $0.21 B a decrease over its 2020 earnings that were of $0.22 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bio-Techne from 2001 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$0.34 B60.07%
2021$0.21 B-1.3%
2020$0.22 B54.23%
2019$0.14 B4.5%
2018$0.13 B7.41%
2017$0.12 B4.72%
2016$0.12 B-16.38%
2015$0.14 B-9.16%
2014$0.16 B2.48%
2013$0.15 B-2.16%
2012$0.16 B-3.5%
2011$0.16 B6.2%
2010$0.15 B-0.59%
2009$0.15 B2.78%
2008$0.15 B14.95%
2007$0.13 B15.14%
2006$0.11 B11.66%
2005$0.10 B17.05%
2004$88.43 M18.06%
2003$74.9 M26.18%
2002$59.36 M22.74%
2001$48.36 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$7.92 B 2,168.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.99 B 469.53%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.55 B-827.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.38 B 2,300.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.62 B 79.76%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-$18.27 M-105.23%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.85 B-2,344.11%๐Ÿ‡บ๐Ÿ‡ธ USA